Semaglutide Injection
Patient-specific GLP-1 formulation, compounded to order in our sterile ISO-5 facility.
- Dose
- 2.5 mg/mL
- Form
- Injectable — multi-dose vial
- Quantity
- 1 mL · 2 mL · 4 mL
- Storage
- Refrigerate 2–8 °C · protect from light
Directions
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
- Example: Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Clinical Reason Statement
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
i.e. Lorem ipsum dolor sit amet consectetur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit:
- LifeFile eRx Portal: Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- API Integrations: Lorem ipsum dolor sit amet, consectetur adipiscing elit.
- Faxed Prescriptions: Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Prescribing Tip
Directions must be prescribed in units — e.g. "Inject 10 units on insulin syringe subcutaneously once weekly." A Clinical Reason Statement is required when prescribing semaglutide (e.g. prescribed for flexible dosing/titration not achievable with the commercial product).
California prescriptions require a diagnosis code.
503A patient-specific
Every formulation is compounded for an individual patient, pursuant to a prescription.
Tested at every step
Rigorous quality control and quality assurance, in a facility that exceeds USP <797> standards.
Custom solutions
Need a different strength, base or format? Contact us — our catalog is not all-inclusive.
